Nitya Anand focuses her practice on intellectual property litigation matters. She counsels life sciences, chemical and technology companies on patent and case strategies. An experienced litigator, she translates complex issues and technical information into successful arguments in both the courtroom and the boardroom.
Nitya implements successful case strategies in both judge and jury trials in district courts as well as in proceedings before the US Patent and Trademark Office, US International Trade Commission and Court of Appeals for the Federal Circuit. She has significant experience in the pharmaceutical (small molecules and biologics), chemical, agricultural. and medical device industries. She frames and simplifies the complicated technical issues of those fields into judge-, jury-, and stakeholder-friendly analyses. Nitya also regularly assists clients with due diligence in support of the purchase or sale of drugs or royalty streams, patent prosecution, infringement and validity opinion assessments and IP licensing.
Prior to practicing law, Nitya worked in diversity and inclusion affairs in a university setting. She maintains an active pro bono practice.
Represented an American multinational biopharmaceutical company in an inter partes review proceeding relating to methods of refolding biologic proteins*
Represented a leading Japanese pharmaceutical firm in numerous Hatch-Waxman actions in relation to generic versions of its anti-ulcer drug*
Represented a global ingredient solutions company in patent infringement suit relating to phosphorylated resistant starches*
Represented a Japanese pharmaceutical company, a Japanese glass manufacturing company, and an American pharmaceutical company in a Hatch-Waxman litigation and an inter partes review proceeding, obtaining favorable final decision upholding validity*
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.